• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Differential therapy with beta blockers. What is their value, what are the risks?].

作者信息

Bäumer A T, Erdmann E

机构信息

Klinik III für Innere Medizin, Universität zu Köln.

出版信息

MMW Fortschr Med. 2001 Sep 27;143(39):36-8.

PMID:11680926
Abstract

The selective beta blockers metoprolol, bisoprolol and atenolol, but also the non-selective beta blocker carvedilol, are drugs with individually specific properties that are widely prescribed for a wide range of indications. Modern beta blockers are safe drugs with a low profile of side effects, which, applied with proper consideration being given to contraindications, rarely produce serious side effects such as bradyarrhythmia, bronchial obstruction, or aggravation of heart failure. Their prognostic benefit, for example, in the treatment of post-myocardial infarction patients, or in cardiac insufficiency, has been demonstrated in large randomized clinical trials.

摘要

相似文献

1
[Differential therapy with beta blockers. What is their value, what are the risks?].
MMW Fortschr Med. 2001 Sep 27;143(39):36-8.
2
Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.β受体阻滞剂在慢性心力衰竭和慢性阻塞性肺疾病患者中的差异:一项随机交叉试验。
J Am Coll Cardiol. 2010 Apr 27;55(17):1780-7. doi: 10.1016/j.jacc.2010.01.024.
3
[Use of beta-blockers in heart failure].
Nihon Rinsho. 2003 May;61(5):816-20.
4
Comparative effectiveness of beta-adrenergic antagonists (atenolol, metoprolol tartrate, carvedilol) on the risk of rehospitalization in adults with heart failure.β-肾上腺素能拮抗剂(阿替洛尔、酒石酸美托洛尔、卡维地洛)对成年心力衰竭患者再住院风险的比较疗效。
Am J Cardiol. 2007 Aug 15;100(4):690-6. doi: 10.1016/j.amjcard.2007.03.084. Epub 2007 Jun 26.
5
[Use of beta blockers in cardiovascular diseases and bronchial asthma/COPD].[β受体阻滞剂在心血管疾病和支气管哮喘/慢性阻塞性肺疾病中的应用]
Internist (Berl). 2004 Feb;45(2):221-7. doi: 10.1007/s00108-003-1093-3.
6
Beta-blockers in heart failure: how far have we progressed?心力衰竭中的β受体阻滞剂:我们取得了多大进展?
Postgrad Med. 2002 Nov;112(5 Suppl Unanswered):7-15. doi: 10.3810/pgm.11.2002.suppl22.115.
7
Beta-blockers in heart failure: are pharmacological differences clinically important?心力衰竭中的β受体阻滞剂:药理学差异在临床上重要吗?
Heart Fail Rev. 2004 Apr;9(2):123-30. doi: 10.1023/B:HREV.0000046367.99002.a4.
8
[Therapy of heart failure with beta-blockers?].[β受体阻滞剂治疗心力衰竭?]
Z Kardiol. 1997 Jan;86(1):1-8.
9
[New and old beta-blockers in the treatment of heart failure].[新型与传统β受体阻滞剂在心力衰竭治疗中的应用]
Recenti Prog Med. 2002 Feb;93(2):113-24.
10
Beta-blockers in heart failure. Do they improve the quality as well as the quantity of life?心力衰竭中的β受体阻滞剂。它们能改善生活质量和延长寿命吗?
Eur Heart J. 1998 Dec;19 Suppl P:P17-25.